Nanoparticles for the treatment of liver fibrosis

Chronic liver diseases represent a global health problem due to their high prevalence worldwide and the limited available curative treatment options. They can result from various causes, both infectious and noninfectious diseases. The application of nanoparticle (NP) systems has emerged as a rapidly...

Descripción completa

Detalles Bibliográficos
Autores principales: Poilil Surendran, Suchithra, George Thomas, Reju, Moon, Myeong Ju, Jeong, Yong Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614791/
https://www.ncbi.nlm.nih.gov/pubmed/29033567
http://dx.doi.org/10.2147/IJN.S145951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614791/
https://www.ncbi.nlm.nih.gov/pubmed/29033567
http://dx.doi.org/10.2147/IJN.S145951

Ejemplares similares